(0115–0144) Antiphospholipid Syndrome Poster

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Performance of the 2023 and 2006 APS Classification Criteria in Pediatric Patients Diagnosed with APS: A Multisite Cohort Study
Abstract Poster Presenter: Jacqueline A. Madison, MD – University of Michigan
10:30 AM - 12:30 PM Central Time

Analysis of Antiphosphatidylserine/prothrombin Antibodies as a Predictor of Lupus Anticoagulant in the Pediatric Population
Abstract Poster Presenter: Jonathan Marilao, MD – University of Texas Southwestern
10:30 AM - 12:30 PM Central Time

Single-cell Profiling of Dermal Endothelial Cells Reveals Potential Cell-Cell Interactions in Patients with APS and a History of Cardiac Valve Disease
Abstract Poster Presenter: Jason Knight, MD, PhD – University of Michigan
10:30 AM - 12:30 PM Central Time

Dysfunctional Mitophagy Propels Neutrophil Hyperactivity and Thrombosis in Antiphospholipid Syndrome
Abstract Poster Presenter: Ajay Tambralli, MD – University of Michigan
10:30 AM - 12:30 PM Central Time

High-dimensional Spectral Flow Cytometry Reveals a Unique Distribution of Circulating B Cells in Patients with Antiphospholipid Syndrome
Abstract Poster Presenter: Yuzhou Gan, MBBS – University of Michigan
10:30 AM - 12:30 PM Central Time

Outcome Of Patients With Non-Criteria Manifestations Of Primary Antiphospholipid Syndrome Treated With Immunosuppressants -A Single Centre Study
Abstract Poster Presenter: Sindhuja Rajendran, MBBS, MD, DM, MRCP – Christian Medical College, Vellore
10:30 AM - 12:30 PM Central Time

Neutrophil Gasdermin D Pores as Potential Therapeutic Targets in APS-Associated Thromboinflammation
Abstract Poster Presenter: NaveenKumar Somanathapura, PhD – University of Michigan
10:30 AM - 12:30 PM Central Time

Defining a Consensus for Critical Data Fields for International Pediatric Antiphospholipid Syndrome Research
Abstract Poster Presenter: Jheel Bhatt, MD – Advent Health Orlando
10:30 AM - 12:30 PM Central Time

Beyond Thrombosis: Histological Spectrum, Predictors and Outcomes of Renal Involvement in Primary Antiphospholipid Syndrome: A Single-Centre Cohort Study
Abstract Poster Presenter: Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH
10:30 AM - 12:30 PM Central Time

Prognosis of Cardiac Involvement in Antiphospholipid Syndrome
Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
10:30 AM - 12:30 PM Central Time

The IFN Signature is Less Pronounces in Primary Antiphospholipid Syndrome Compared with other Systemic Autoimmune Diseases
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
10:30 AM - 12:30 PM Central Time

Increased Expression of Gas6 and Its Tyrosine Kinase Receptor Tyro3 Are Associated with Antiphospholipid Syndrome
Abstract Poster Presenter: Liling Xu, PhD – Peking University People's Hospital
10:30 AM - 12:30 PM Central Time

Cerebral small vessel disease in antiphospholipid syndrome: subtypes and total burden of cSVD on MRI
Abstract Poster Presenter: Chun Li, n/a – Peking University People's Hospital
10:30 AM - 12:30 PM Central Time

Plasminogen activator inhibitor 1 increases thrombotic risk in Antiphospholipid syndrome
Abstract Poster Presenter: Koshy Thomas, MD, DM – Christian Medical College, Vellore
10:30 AM - 12:30 PM Central Time

Differences in cardiovascular risk factor control between primary and systemic lupus erythematosus-related antiphospholipid syndrome in a multiethnic cohort of 1003 patients with antiphospholipid syndrome: the SUrvey of cardiovascular disease Risk Factors (SURF) in SLE and APS project
Abstract Poster Presenter: Maria Tektonidou, PhD – National and Kapodistrian University of Athens
10:30 AM - 12:30 PM Central Time

Cytokine profiles in antiphospholipid syndrome
Abstract Poster Presenter: Xiangjun Liu, MBBS – Peking University
10:30 AM - 12:30 PM Central Time

Libman-Sacks Endocarditis in APS: A Case-Control Study of Clinical and Serologic Features
Abstract Poster Presenter: Kyla Rodgers, MD, PhD – University of Michigan
10:30 AM - 12:30 PM Central Time

Single-cell RNA sequencing of skin reveals vascular dysregulation in antiphospholipid syndrome
Abstract Poster Presenter: Ecem Sevim, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
10:30 AM - 12:30 PM Central Time

Risk Factors for Antiphospholipid Syndrome-associated Nephropathy: A Retrospective Cohort Analysis
Abstract Poster Presenter: Xiaohan Wei, n/a – Shanghai JiaoTong University
10:30 AM - 12:30 PM Central Time

Single-cell atlas reveals the central-and-peripheral immune remodeling mechanism and clinical benefits of talitacicept therapy in patients with primary antiphospholipid syndrome
Abstract Poster Presenter: Haoyu Pan, MD – Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
10:30 AM - 12:30 PM Central Time

Thrombin Generation Assays Inform Hypercoagulability Mediated by Antiphospholipid Antibodies in Children with Systemic Lupus Erythematosus
Abstract Poster Presenter: Elizabeth Sloan, MD – UT Southwestern
10:30 AM - 12:30 PM Central Time

When One Isn't Enough: Does Adding IgM Worsen the Antiphospholipid Syndrome Phenotype?
Abstract Poster Presenter: Santiago Dans Caballero, MD – H. U. Reina Sofía
10:30 AM - 12:30 PM Central Time

Are Thrombotic or Obstetric Events Associated with Additional Clinical Domains in Triple Antiphospholypid Syndrome?
Abstract Poster Presenter: Cristina Rocamora Gisbert, PhD – Universitat Autònoma de Barcelona
10:30 AM - 12:30 PM Central Time

Rituximab in Antiphospholipid Syndrome: aPL Titer Decline and Clinical Outcomes
Abstract Poster Presenter: Omer Uludag, MD – Istanbul Faculty of Medicine
10:30 AM - 12:30 PM Central Time

Duration of Anticoagulation in Antiphospholipid Antibody-positive Patients: Results from an AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Survey
Abstract Poster Presenter: Zeynep Belce Erton, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

The role of low profile antiphospholipid antibodies and adverse pregnancy outcomes.
Abstract Poster Presenter: Eugenia Chock, MD – Yale School of Medicine
10:30 AM - 12:30 PM Central Time

The Prevalence and Clinical Significance of Heritable Thrombophilia in Antiphospholipid Antibody Positive Patients: Descriptive Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
Abstract Poster Presenter: Emre Sahin, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

The Prevalence and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibody Isotypes in Antiphospholipid Antibody Positive Patients: Descriptive Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Registry
Abstract Poster Presenter: Emre Sahin, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Evaluating Artificial Intelligence for Diagnosing Antiphospholipid Syndrome in Pulmonary Embolism Case Reports: A Prompt-Based Analysis
Abstract Poster Presenter: Sami Rabah, MD (he/him/his) – Lincoln Medical Center
10:30 AM - 12:30 PM Central Time

Landscape of Primary Antiphospholipid Syndrome: Clinical Spectrum, Serology, and Predictors of Damage in a Single Center Cohort of 233 Patients
Abstract Poster Presenter: Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH